Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €47.79 EUR
Change Today +0.89 / 1.89%
Volume 0.0
WGB On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 9:34 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

greatbatch inc (WGB) Snapshot

Open
€46.81
Previous Close
€46.91
Day High
€47.79
Day Low
€46.81
52 Week High
04/1/15 - €53.15
52 Week Low
10/1/14 - €33.14
Market Cap
1.2B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
25.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GREATBATCH INC (WGB)

Related News

No related news articles were found.

greatbatch inc (WGB) Related Businessweek News

View More BusinessWeek News

greatbatch inc (WGB) Details

Greatbatch, Inc. designs, manufactures, and sells medical devices and components for the cardiac, neuromodulation, orthopaedics, portable medical, vascular, energy, and clinical markets worldwide. It operates in two segments, Greatbatch Medical and QiG Group. The company offers cardiac and neuromodulation products, including batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, implantable stimulation leads, and enclosures used in implantable medical devices; and orthopaedics products, such as hip and shoulder joint reconstruction implants, bone plates and spinal devices, and instruments and delivery systems used in hip and knee replacement, trauma fixation, extremity, and spine surgeries. It also provides vascular products comprising off-the-shelf introducers, steerable sheaths, and components for catheters that deliver minimally invasive therapies for coronary and neurovascular disease, peripheral vascular disease, interventional radiology, vascular access, atrial fibrillation, and interventional cardiology, as well as products for medical imaging and drug and pharmaceutical delivery. In addition, Greatbatch, Inc. offers customized battery power and management systems, charging and docking stations, and power supplies; non-rechargeable and rechargeable battery solutions, which are used in the portable medical, energy, military, and environmental markets; and rechargeable battery packs, such as electronics, charging, and battery management systems that are used in critical and life-saving applications. Further, it provides implantable pulse generators, programmer systems, and patient wands; and neural interface technology, components, and systems. The company serves multi-national original equipment manufacturers, numerous scientists, hospitals, and universities, as well as research companies and institutes, and early stage medical device companies. Greatbatch, Inc. was founded in 1970 and is headquartered in Frisco, Texas.

3,690 Employees
Last Reported Date: 03/3/15
Founded in 1970

greatbatch inc (WGB) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $700.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $375.7K
Executive Vice President of Global Operations
Total Annual Compensation: $336.6K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $248.5K
Executive Vice President of Global Sales & Ma...
Total Annual Compensation: $287.5K
Compensation as of Fiscal Year 2014.

greatbatch inc (WGB) Key Developments

Greatbatch, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended July 3, 2015; Provides Earnings Guidance for the Year 2015

Greatbatch, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended July 3, 2015. For the quarter, the company reported sales of $174,890,000 compared to $172,081,000 a year ago. Operating income was $13,034,000 compared to $19,539,000 a year ago. Income before provision for income taxes was $11,935,000 compared to $18,132,000 a year ago. Net income was $9,283,000 or $0.35 per diluted share compared to $12,348,000 or $0.48 per diluted share a year ago. Adjusted operating income was $22,243,000 compared to $24,188,000 a year ago. Adjusted net income was $16,733,000 or $0.64 per diluted share compared to $15,784,000 or $0.61 per diluted share a year ago. Adjusted EBITDA was $31,259,000 compared to $33,497,000 a year ago. Cash flows provided by operating activities was $15.2 million decreased 22% in comparison to the second quarter of 2014. Capital expenditures were $6.8 million compared to prior year second quarter capital expenditures of $6.0 million. For the six months, the company reported sales of $336,210,000 compared to $346,362,000 a year ago. Operating income was $22,423,000 compared to $42,063,000 a year ago. Income before provision for income taxes was $21,755,000 compared to $40,193,000 a year ago. Net income was $17,291,000 or $0.66 per diluted share compared to $27,270,000 or $1.06 per diluted share a year ago. Adjusted operating income was $40,187,000 compared to $46,872,000 a year ago. Adjusted net income was $31,290,000 or $1.19 per diluted share compared to $29,852,000 or $1.16 per diluted share a year ago. Adjusted EBITDA was $58,381,000 compared to $65,433,000 a year ago. The company provided earnings guidance for the year 2015. For the year, the company expects sales in the rage of $715 million to $730 million. GAAP operating income as a % of sales in the range of 7.5% to 8.5%. Adjusted operating income as a % of sales in the range of 13.7% to 14.0%. Capital expenditures in the range of $40 million to $50 million. GAAP effective tax rate of 23.5%. Adjusted effective tax rate in the range of 21% to 24%. GAAP diluted EPS in the range of $1.43 to $1.53. Adjusted diluted EPS in the range of $2.61 to $2.71. Adjusted operating cash flows are expected to be between $80 million and $100 million.

Joseph A. Miller, Jr. to Step Down from Greatbatch's Board of Directors

Greatbatch, Inc. announced it has filed a Form 10 registration statement with the U.S. Securities and Exchange Commission for its proposed tax-free spin-off of its neuromodulation subsidiary, QiG Group LLC, to be known post-spin as Nuvectra Corporation. The new company will immediately benefit from two highly experienced leaders. Neurostimulation market veteran Scott Drees has been named as Nuvectra's chief executive officer. In addition, Dr. Joseph A. Miller, Jr. will step down from Greatbatch's board of directors immediately prior to the completion of the spin-off to accept an appointment as a director and chairman of the board of Nuvectra.

Greatbatch, Inc. Announces Board Appointments

Greatbatch, Inc. announced that Jean Hobby, M. Craig Maxwell and Filippo Passerini have been elected to its Board of Directors. Ms. Hobby served as a global strategy officer at PricewaterhouseCoopers, LLP (PWC) from 2013 until her recent retirement. During a 33-year career at PWC, she also held roles as its U.S. Sector leader where her responsibilities included P&L, daily operations, PCAOB interaction and global clients, and as PWC's chief financial officer with responsibility for finance, treasury, mergers & acquisitions, external reporting, compliance, governance and real estate. Mr. Maxwell is the vice president and chief technology and innovation officer for Parker Hannifin Corporation, the global leader in motion and control technologies and systems. He leads new and emerging markets growth and drives new product development, as well as oversees Parker Hannifin's technology incubator to facilitate cross-group innovation opportunities. Prior to Parker Hannifin, Mr. Maxwell held a number of engineering positions with Stanadyne Corporation's Diesel Systems Group. Mr. Passerini recently joined the Carlyle Group as an operating executive in U.S. Buyouts following his retirement from a distinguished career at the Procter & Gamble Company (P&G), where he most recently served as officer on special assignment to the president and CEO. Prior to that, Mr. Passerini held roles as P&G's group president, Global Business Services and as chief information officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WGB:GR €47.79 EUR +0.89

WGB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Analogic Corp $80.55 USD +0.41
Astronics Corp $62.00 USD +0.57
Merit Medical Systems Inc $25.56 USD +0.39
Saft Groupe SA €37.17 EUR +0.49
Universal Electronics Inc $51.84 USD -0.01
View Industry Companies
 

Industry Analysis

WGB

Industry Average

Valuation WGB Industry Range
Price/Earnings 31.4x
Price/Sales 2.0x
Price/Book 2.2x
Price/Cash Flow 30.6x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GREATBATCH INC, please visit www.greatbatch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.